Steris Plc (STE31) Return on Investment ROI from the first quarter of 2026 to first quarter of 2022 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Steris Plc  (NYSE: STE31)


Steris Plc's ROI from its first quarter of 2026 to the first quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Steris Plc's ROI in the first quarter of 2026?
Steris Plc achieved a return on average invested assets (ROI) of 1.2 % in its first quarter of 2026, which is below Steris Plc's average return on investment, which stands at 5.81%.

ROI has improved compared to -0.28% in the third quarter of 2023, due to net income growth.

Within the Healthcare sector 21 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2023 from to 3277.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
I. Quarter		 (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter
Y / Y Investment Change TTM 4.38 % 22.29 % 11.44 % 41.26 % 87.79 %
Y / Y Net Income Change TTM -50.65 % - - 466.85 % 175.52 %
Investment (TTM) in Millions 9,467 10,514 9,628 10,291 10,514
Return On Investment (TTM) 1.2 % -0.28 % -0.1 % 4 % 2.54 %
STE31's Overall Ranking # 3277 # # # #
Seq. Investment Change TTM -2.56 % 13.1 % -3.59 % -1.77 % 14.17 %
Seq. Net Income Change TTM - - - 54.62 % -12.94 %
Net Income (TTM) in Millions 120 -29 -9 376 243

STE31 Company Profile >> Back to STE31 Roi Comparisons >> See Annual STE31 Return On Investment



Return On Investment STE31's Ranking
Within: No.
Industry # 9
Sector # 22
Overall # 3277

Return On Investment Statistics
High Average Low
12.78 %
5.81 %
-0.27 %
(Sep 30 2019)  







Financial Statements
Steris Plc's I. Quarter Investments $ 9,467 Millions STE31's Balance sheet
Steris Plc's I. Quarter Income $ 201 Millions Quarterly STE31's Income Statement
STE31's Income by Division See STE31's Income by Division


STE31 Annual Return On Investment (Mar 31 2022)
2022		 (Mar 31 2021)
2021		 (Mar 31 2020)
2020		 (Mar 31 2017)
2019
Total Investments in Millions 10,514 5,770 4,775 4,762 0
Y / Y Investment Growth 82.21 % 20.85 % 0.26 % - -
Net Income in Millions 243 397 408 111 0
Y / Y Net Income Growth -38.8 % -2.68 % 268.62 % - -
Annual Return On Investment 2.31 % 6.88 % 8.54 % 2.32 % -


Annual Roi Comment
In the fiscal year 2022 ROI decreased relative to the previous year to 2.31 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
STE31's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for STE31's Competitors
Subscribers only: Roi for Steris Plc's Suppliers
Subscribers only: Return On Investment for STE31's Customers

Other Ratios
STE31's Roa STE31's Inventory Turnover Ratio STE31's Growth Rates STE31's Dividend Statistics
STE31's Profitability Ratios STE31's Asset Turnover Ratio STE31's Dividend Growth
STE31's Roe STE31's Valuation Ratios STE31's Financial Strength Ratios STE31's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %
Pfizer Inc  2.53 %
Mimedx Group Inc   2.38 %
Bio rad Laboratories Inc   2.34 %
Lifemd Inc   2.32 %
Alkermes Plc   2.31 %
Becton Dickinson And Company  2.22 %
Revvity Inc  2.18 %
Envista Holdings Corporation  2.06 %
Immucell Corporation  1.95 %
Atricure Inc   1.84 %
Black Hawk Acquisition Corporation  1.79 %
Omada Health Inc   1.70 %
Arvinas Inc   1.53 %
Repligen Corp  1.41 %
Cormedix Inc   1.31 %
Pacira Biosciences inc   1.29 %
Waters Corporation  1.20 %
Surgery Partners Inc   1.02 %
Warby Parker Inc   0.98 %
Staar Surgical Co  0.98 %
Biomarin Pharmaceutical Inc  0.91 %
Icu Medical Inc  0.87 %
Radnet Inc   0.45 %
Delcath Systems Inc   0.45 %

Date modified: 2026-09-12T06:23:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.